Colon cancer breakthrough keeps patients cancer-free for nearly 3 years

A new clinical trial suggests that giving immunotherapy before surgery may dramatically improve outcomes for certain colorectal cancer patients. In the NEOPRISM-CRC study, patients treated with a short course of immunotherapy instead of chemotherapy after surgery have remained cancer-free for…

Click here to view the original article.